aTyr Pharma, Inc.
- ATYR
- NASDAQ
- Biotechnology
- Immunology Therapeutics
- tRNA Synthetase-Based Drugs
$0.18
Today +3.79%Quote Oct 19, 2026, 01:54 PM UTC
−53.78%over the last month
Max drawdown −53.8%From 1-month high −53.8%3 months −64.2%
Our viewPro
The call stays with Pro
Verdict, why now, and the write-up open with Pro. New accounts get 14 days of Pro free.
Market value
$17.7M
Quote Oct 19
Next earnings
Nov 5
Expected, not confirmed
Analyst target
$5.13
+2740.5% from here
Floor
$0.18
0.3% below price
Where the price sits
10 analysts
Analyst range, low to high
$1.00$17.00
- Price $0.18
- Resistance $0.21
- Consensus $5.13
The price is just above its floor. Analysts' average target sits about 2741% higher. Their range is wide.
The call stays with Pro
7 locked chapters- What to do with this namePro
- Why nowPro
- Why this stockPro
- Section write-upsPro
- Story timelinePro
- News briefPro
- Ask about ATYRPro
Verdict, why now, and the write-up open with Pro. New accounts get 14 days of Pro free.
Log in — 14 days freeWhere the money comes from
No revenue split by segment on file.
Industry
Biotechnology
Employees
58